Wei Lv Selected Research

Paclitaxel (Taxol)

6/2022	Multifunctional Hybrid Hydrogel System Enhanced the Therapeutic Efficacy of Treatments for Postoperative Glioma.
1/2022	In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma.
12/2021	Tumor-Associated Neutrophil Extracellular Traps Regulating Nanocarrier-Enhanced Inhibition of Malignant Tumor Growth and Distant Metastasis.
1/2020	Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles.
10/2016	Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles.
11/2015	Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Lv Research Topics

Disease

50	Neoplasms (Cancer) 10/2022 - 12/2007
10	Glioma (Gliomas) 06/2022 - 12/2014
10	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2011
9	Ischemic Stroke 11/2022 - 07/2015
9	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2013
7	Inflammation (Inflammations) 11/2022 - 01/2015
6	Stroke (Strokes) 11/2022 - 10/2016
6	Carcinogenesis 02/2022 - 06/2016
6	Spinal Cord Injuries (Spinal Cord Injury) 11/2021 - 01/2016
6	Infections 05/2021 - 02/2007
6	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2015
5	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 10/2010
5	Hypoxia (Hypoxemia) 03/2021 - 11/2017
5	Pulmonary Embolism 01/2014 - 01/2013
4	Tuberculosis (Tuberculoses) 01/2022 - 01/2019
4	Nasal Polyps (Nasal Polyp) 01/2022 - 02/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2006
4	Body Weight (Weight, Body) 12/2021 - 01/2013
4	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 11/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 12/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2017
3	Carcinoma (Carcinomatosis) 04/2022 - 08/2013
3	Rhinosinusitis 01/2022 - 02/2016
3	Esophageal Squamous Cell Carcinoma 12/2021 - 03/2017
3	Lung Neoplasms (Lung Cancer) 06/2021 - 12/2014
3	Thrombosis (Thrombus) 01/2021 - 01/2019
3	Poisoning 05/2020 - 05/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2010
3	Brain Neoplasms (Brain Tumor) 11/2017 - 11/2015
3	Ischemia 10/2016 - 12/2012
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016 - 01/2013
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 10/2016
2	Reperfusion Injury 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 06/2020
2	Conversion Disorder (Astasia Abasia) 12/2021 - 10/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 01/2021
2	Myocardial Infarction 01/2021 - 01/2020
2	Cognitive Dysfunction 11/2020 - 01/2020
2	Hypersensitivity (Allergy) 01/2020 - 10/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 02/2016
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2019
2	Proteinuria 01/2020 - 01/2013

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 06/2022 - 03/2010
14	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2013
10	Peptides (Polypeptides)IBA 01/2022 - 07/2015
8	Long Noncoding RNAIBA 02/2022 - 01/2016
8	Biological ProductsIBA 01/2022 - 02/2007
6	Therapeutic UsesIBA 06/2022 - 07/2015
6	Paclitaxel (Taxol)FDA LinkGeneric 06/2022 - 11/2015
6	Neuroprotective AgentsIBA 01/2019 - 01/2013
5	Phosphotransferases (Kinase)IBA 03/2021 - 12/2014
4	ProdrugsIBA 06/2022 - 11/2017
4	Small Interfering RNA (siRNA)IBA 02/2022 - 08/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2016
4	CateninsIBA 12/2021 - 12/2016
4	CytokinesIBA 02/2021 - 01/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2013
4	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 11/2017 - 11/2015
3	Glutathione (Reduced Glutathione)IBA 06/2022 - 11/2017
3	Messenger RNA (mRNA)IBA 04/2022 - 01/2013
3	Subunit VaccinesIBA 01/2022 - 02/2021
3	Fibroblast Growth Factor-23IBA 01/2022 - 07/2017
3	LipidsIBA 12/2021 - 01/2017
3	AntibodiesIBA 11/2021 - 01/2013
3	Indicators and Reagents (Reagents)IBA 06/2021 - 08/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2015
3	Immunoglobulins (Immunoglobulin)IBA 10/2018 - 08/2017
3	FlavonoidsIBA 04/2018 - 01/2017
3	Gemcitabine FDA Link 11/2017 - 09/2015
3	Selective Estrogen Receptor Modulators (SERM)IBA 11/2016 - 03/2015
3	Aromatase InhibitorsIBA 11/2016 - 09/2013
3	Aromatase (CYP19)IBA 01/2016 - 06/2013
3	Estrogen ReceptorsIBA 01/2016 - 06/2013
2	C-Reactive ProteinIBA 11/2022 - 10/2017
2	HydrogelsIBA 06/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2017
2	Immunoglobulin E (IgE)IBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 12/2021 - 08/2017
2	EnzymesIBA 03/2021 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 03/2021 - 09/2015
2	VaccinesIBA 02/2021 - 07/2015
2	AndrogensIBA 01/2021 - 01/2017
2	JNK Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2020
2	GlucocorticoidsIBA 01/2021 - 11/2017
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 01/2015
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020 - 10/2016
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2017
2	LigandsIBA 01/2020 - 01/2014
2	Phosphorus (Red Phosphorus)IBA 01/2020 - 07/2017
2	Protein Isoforms (Isoforms)IBA 01/2020 - 09/2015

Therapy/Procedure

26	Therapeutics 07/2022 - 08/2006
10	Drug Therapy (Chemotherapy) 06/2022 - 10/2016
6	Immunotherapy 02/2022 - 01/2021
5	Electroacupuncture 11/2021 - 01/2016
2	Precision Medicine 05/2022 - 02/2016
2	Length of Stay 01/2022 - 01/2022
2	Complementary Therapies (Alternative Medicine) 11/2021 - 12/2012
2	Ligation 12/2020 - 12/2012